These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 1617669)

  • 1. Genetic modification of a murine fibrosarcoma to produce interleukin 7 stimulates host cell infiltration and tumor immunity.
    McBride WH; Thacker JD; Comora S; Economou JS; Kelley D; Hogge D; Dubinett SM; Dougherty GJ
    Cancer Res; 1992 Jul; 52(14):3931-7. PubMed ID: 1617669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of immune responses in the eradication of IL-1 alpha gene-transduced tumour cells: mechanisms of tumour rejection and immunotherapeutical implications.
    Apte RN; Douvdevani A; Zoller M; White RM; Dvorkin T; Shimoni N; Huleihel M; Fima E; Hacham M; Voronov E
    Folia Biol (Praha); 1994; 40(1-2):1-18. PubMed ID: 7958060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Melanoma differentiation-associated gene-7 (mda-7)/interleukin (IL)-24 induces anticancer immunity in a syngeneic murine model.
    Miyahara R; Banerjee S; Kawano K; Efferson C; Tsuda N; Miyahara Y; Ioannides CG; Chada S; Ramesh R
    Cancer Gene Ther; 2006 Aug; 13(8):753-61. PubMed ID: 16543916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of IL-3 gene expression on tumor response to irradiation in vitro and in vivo.
    Chiang CS; Syljuäsen RG; Hong JH; Wallis A; Dougherty GJ; McBride WH
    Cancer Res; 1997 Sep; 57(18):3899-903. PubMed ID: 9307268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokine gene therapy of gliomas: induction of reactive CD4+ T cells by interleukin-4-transfected 9L gliosarcoma is essential for protective immunity.
    Giezeman-Smits KM; Okada H; Brissette-Storkus CS; Villa LA; Attanucci J; Lotze MT; Pollack IF; Bozik ME; Chambers WH
    Cancer Res; 2000 May; 60(9):2449-57. PubMed ID: 10811123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccination with IL-2-secreting tumor cells stimulates the generation of IL-2-responsive T cells and prevents the development of unresponsiveness.
    Zier KS; Salvadori S; Cronin KC; Gansbacher B
    Cancer Gene Ther; 1994 Mar; 1(1):43-50. PubMed ID: 7621237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune phenomena involved in the in vivo regression of fibrosarcoma cells expressing cell-associated IL-1alpha.
    Dvorkin T; Song X; Argov S; White RM; Zoller M; Segal S; Dinarello CA; Voronov E; Apte RN
    J Leukoc Biol; 2006 Jul; 80(1):96-106. PubMed ID: 16707560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin 3 enhances development of tumor-reactive cytotoxic cells by a CD4-dependent mechanism.
    Pulaski BA; McAdam AJ; Hutter EK; Biggar S; Lord EM; Frelinger JG
    Cancer Res; 1993 May; 53(9):2112-7. PubMed ID: 8097675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multicomponent gene therapy vaccines for lung cancer: effective eradication of established murine tumors in vivo with interleukin-7/herpes simplex thymidine kinase-transduced autologous tumor and ex vivo activated dendritic cells.
    Sharma S; Miller PW; Stolina M; Zhu L; Huang M; Paul RW; Dubinett SM
    Gene Ther; 1997 Dec; 4(12):1361-70. PubMed ID: 9472560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of cancer gene therapy in aging: adenocarcinoma cells engineered to release IL-2 are rejected but do not induce tumor specific immune memory in old mice.
    Provinciali M; Argentati K; Tibaldi A
    Gene Ther; 2000 Apr; 7(7):624-32. PubMed ID: 10819579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibrosarcoma cells transduced with the IL-6 gene exhibited reduced tumorigenicity, increased immunogenicity, and decreased metastatic potential.
    Mullen CA; Coale MM; Levy AT; Stetler-Stevenson WG; Liotta LA; Brandt S; Blaese RM
    Cancer Res; 1992 Nov; 52(21):6020-4. PubMed ID: 1394227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful adoptive immunotherapy of murine poorly immunogenic tumor with specific effector cells generated from gene-modified tumor-primed lymph node cells.
    Tanaka H; Yoshizawa H; Yamaguchi Y; Ito K; Kagamu H; Suzuki E; Gejyo F; Hamada H; Arakawa M
    J Immunol; 1999 Mar; 162(6):3574-82. PubMed ID: 10092816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunotherapy of established tumors in mice by intratumoral injection of an adenovirus vector harboring the human IL-2 cDNA: induction of CD8(+) T-cell immunity and NK activity.
    Slos P; De Meyer M; Leroy P; Rousseau C; Acres B
    Cancer Gene Ther; 2001 May; 8(5):321-32. PubMed ID: 11477452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of intracranial tumors by systemic transfer of superantigen-activated tumor-draining lymph node T cells.
    Inoue M; Plautz GE; Shu S
    Cancer Res; 1996 Oct; 56(20):4702-8. PubMed ID: 8840987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insertion of the IL-2 gene decreases tumorigenicity of murine fibrosarcoma.
    Kuśnierczyk H; Załecki P; Pajtasz-Piasecka E; Radzikowski C
    Arch Immunol Ther Exp (Warsz); 1998; 46(4):259-65. PubMed ID: 9779293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune response to somatic cell hybrids between ultraviolet radiation-induced regressor and spontaneous progressor C3H mouse tumor cells.
    Chen PW; Kaba DS; Ananthaswamy HN
    Cancer Res; 1990 Mar; 50(5):1544-9. PubMed ID: 2137370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preclinical evaluation of "whole" cell vaccines for prophylaxis and therapy using a disabled infectious single cycle-herpes simplex virus vector to transduce cytokine genes.
    Ali SA; McLean CS; Boursnell ME; Martin G; Holmes CL; Reeder S; Entwisle C; Blakeley DM; Shields JG; Todryk S; Vile R; Robins RA; Rees RC
    Cancer Res; 2000 Mar; 60(6):1663-70. PubMed ID: 10749137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B7-1 and interleukin 12 synergistically induce effective antitumor immunity.
    Coughlin CM; Wysocka M; Kurzawa HL; Lee WM; Trinchieri G; Eck SL
    Cancer Res; 1995 Nov; 55(21):4980-7. PubMed ID: 7585539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cotransduction of CCL27 gene can improve the efficacy and safety of IL-12 gene therapy for cancer.
    Gao JQ; Kanagawa N; Motomura Y; Yanagawa T; Sugita T; Hatanaka Y; Tani Y; Mizuguchi H; Tsutsumi Y; Mayumi T; Okada N; Nakagawa S
    Gene Ther; 2007 Mar; 14(6):491-502. PubMed ID: 17203106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T lymphocytes infiltrating sites of tumor rejection and progression display identical V beta usage but different cytotoxic activities.
    Kurt RA; Park JA; Panelli MC; Schluter SF; Marchalonis JJ; Carolus B; Akporiaye ET
    J Immunol; 1995 Apr; 154(8):3969-74. PubMed ID: 7706735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.